about
Possible contribution of IGF-1 to depressive disorderDepression in cancer: The many biobehavioral pathways driving tumor progression.Inhibitory effects of 1,25-dihydroxyvitamin D3 and its low-calcemic analogues on staurosporine-induced apoptosis.Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y cells.Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons.Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contributeIgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway.Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cellsStress-induced alterations in 5-HT1A receptor transcriptional modulators NUDR and Freud-1The Beneficial Impact of Antidepressant Drugs on Prenatal Stress-Evoked Malfunction of the Insulin-Like Growth Factor-1 (IGF-1) Protein Family in the Olfactory Bulbs of Adult Rats.Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)The Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver.The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression.The role of zinc in neurodegenerative inflammatory pathways in depression.In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression.Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?New trends in the neurobiology and pharmacology of affective disorders.Neuroendocrine link between stress, depression and diabetes.Crosstalk between contact hypersensitivity reaction and antidepressant drugs.Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.No borna disease virus-specific RNA detected in blood of race horses and jockeys.Antidepressants attenuate the dexamethasone-induced decrease in viability and proliferation of human neuroblastoma SH-SY5Y cells: a involvement of extracellular regulated kinase (ERK1/2).Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice.Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.Antioxidant activity of fluoxetine: studies in mice melanoma model.Study of the cytotoxicity and antioxidant capacity of N/OFQ(1-13)NH2 and its structural analogues.Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells.Effect of some antidepressants on the low corticosterone concentration-induced gene transcription in LMCAT fibroblast cells.Involvement of PI3-K in neuroprotective effects of the 1,25-dihydroxyvitamin D3 analogue - PRI-2191.Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells--a possible interaction with psychotropic drugs.Effects of some new antidepressant drugs on the glucocorticoid receptor-mediated gene transcription in fibroblast cells.Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases.Effect of lipopolysaccharide and antidepressant drugs on glucocorticoid receptor-mediated gene transcription.Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway.Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
P50
Q27002937-3F298414-30BA-4FC1-8AF5-A4B0376AB8ACQ30239759-A7395DD7-2FBA-41E2-B9EE-CBE972AB5A8BQ33300659-3A25F993-66DF-4919-A12C-89CA4E8718E4Q33314385-036FB4F8-C3E3-4F3D-AAD8-B41BE08DC96AQ33935569-68C30BA7-BB2F-4CEA-8123-E8897B8C02D8Q33939777-BEFD59B9-01C1-4CB0-8598-C4A55637B597Q34025130-16432920-07E3-48C4-9AD9-934E53C37BA5Q34276668-7DD888D7-29DC-4DD1-9FA2-EE2748144464Q34389771-63704767-66A1-4187-AE6E-67787365BEBFQ34405435-2D461013-0B38-4C35-88AC-9F43CC310CDAQ34418779-CFF86686-F98E-43C2-8469-850AA944232FQ34904703-0D8C7D6B-1C4E-41BE-9594-A3CBE65303D9Q35170354-F683C303-1FCF-403F-972E-933FF1FB3658Q35887982-B3AE7839-921D-4D27-88E1-8215158F2B2CQ36460423-29224D2A-AA9A-4CA4-95B5-0B1D9508B3E1Q36516368-15B82078-3BC1-4A42-9481-05452879311BQ37099353-04FCB6BE-4335-45AE-B8ED-F58DDB87ED75Q37408016-A83CA787-7D5A-4955-814D-808936045232Q37692603-B31EDB67-F377-4528-949D-6F9A919D271BQ37786688-352CF8E0-BE27-43E5-9245-E75C74E0FC6BQ38189135-1FC6C5DB-FE1B-4050-A142-95FCFEFBC014Q38189542-C28B5A67-17DA-45D4-A5A5-AF0C743EB846Q38189558-7FF31622-B7EB-4476-BCF4-8670CA6676D6Q38189566-6560AF59-97EA-4C77-B9E9-DA58313E47D8Q38454097-D5EA98A7-8982-4699-B78B-4638812C931CQ38510048-B8029342-AF9A-4F1F-801B-EF979D19B3DEQ39116930-2F29F8A5-D768-4966-80BA-E54A11263D74Q39452204-A647196B-4033-498A-9C83-994781432497Q39651794-F2BB4712-F887-48EC-A6F6-94E54B3382B5Q39661881-1FC54EBD-69C1-469B-BC44-27E8ACAE0C69Q39750953-B1E1D0DB-76C1-456A-B88F-4295CE43ABB3Q39907464-0A9411D6-F18B-4F05-9262-333141654E18Q39987607-25EDEDCE-3374-4F48-8C7B-E5BD671B8E48Q40183598-13CF2208-152A-4D7F-B313-18AC9A307D10Q40297144-5D74ABB1-CF9B-40B3-A257-4354FC9BC879Q40335471-56F695A3-0464-44E4-8E40-019A3B186071Q40365362-18269035-6A57-46F2-9F3C-27136F319F2FQ40380114-A0DD26FC-6B55-4B88-B848-4CF5E608ECCDQ40401996-017A85A1-2D97-437C-A8BC-AEFF6F8B1648Q40536629-BCD888BE-A51F-4536-AA57-D7F093548051
P50
description
Pools onderzoekster
@nl
researcher ORCID ID = 0000-0003-4401-5055
@en
name
Marta Kubera
@ast
Marta Kubera
@ca
Marta Kubera
@cs
Marta Kubera
@en
Marta Kubera
@es
Marta Kubera
@ga
Marta Kubera
@gl
Marta Kubera
@hr
Marta Kubera
@hsb
Marta Kubera
@it
type
label
Marta Kubera
@ast
Marta Kubera
@ca
Marta Kubera
@cs
Marta Kubera
@en
Marta Kubera
@es
Marta Kubera
@ga
Marta Kubera
@gl
Marta Kubera
@hr
Marta Kubera
@hsb
Marta Kubera
@it
altLabel
Marta Wanda Kubera
@pl
prefLabel
Marta Kubera
@ast
Marta Kubera
@ca
Marta Kubera
@cs
Marta Kubera
@en
Marta Kubera
@es
Marta Kubera
@ga
Marta Kubera
@gl
Marta Kubera
@hr
Marta Kubera
@hsb
Marta Kubera
@it
P214
P106
P1153
7003610589
P1412
P1559
Marta Kubera
@pl
P21
P214
P27
P31
P3124
P496
0000-0003-4401-5055
P734
P7859
viaf-163999752